Home> Products> oral pancreatic enzyme capsules

{ "products": [ { "_id": "68beb3498d01aa56733d32d9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Rivastigmine capsules IP 3 mg", "description": "PYRITIGMIN RIVA 3\nRivastigmine Capsules IP 3 mg\nPyritigmin Riva 3 is a trusted and effective formulation containing Rivastigmine Capsules IP 3 mg, designed to support patients suffering from cognitive decline associated with Alzheimer’s disease and Parkinson’s disease dementia. Manufactured with precision and care by Steris Healthcare, this medication belongs to the class of cholinesterase inhibitors and works by improving communication between nerve cells in the brain.\nAlzheimer’s disease and Parkinson’s disease dementia are progressive neurological conditions that impair memory, thinking, and overall cognitive function. While there is currently no cure, Pyritigmin Riva 3 offers symptomatic relief by enhancing mental clarity, reducing memory loss, and helping patients maintain daily functional independence for longer.\nComposition\nActive Ingredient: Rivastigmine Capsules IP 3 mg\nBrand Name: Pyritigmin Riva 3\nFormulation: Hard gelatin capsules\nUses of Rivastigmine Capsules (Pyritigmin Riva 3)\nAlzheimer’s Disease: Helps reduce memory loss, confusion, and cognitive decline.\nParkinson’s Disease Dementia: Improves focus, alertness, and reduces confusion.\nMild to Moderate Dementia: Enhances daily living activities and maintains patient independence.\nCognitive Function Support: Improves learning ability and attention span.\nHow Does Pyritigmin Riva 3 Work?\nRivastigmine, the main component of Pyritigmin Riva 3, works as a cholinesterase inhibitor. It blocks the enzymes acetylcholinesterase and butyrylcholinesterase, which break down acetylcholine—a neurotransmitter essential for memory and learning. By preventing its breakdown, Rivastigmine increases acetylcholine levels in the brain, thereby improving nerve cell communication.\nThis mechanism slows the worsening of symptoms, giving patients more time to maintain their mental functions and quality of life.\nDosage and Administration\nTypical Dose: One capsule of Pyritigmin Riva 3 (Rivastigmine 3 mg) twice daily with food, or as directed by your doctor.\nTitration: The dose may be adjusted gradually depending on tolerance and effectiveness.\nAdministration:\nSwallow the capsule whole with a glass of water.\nDo not crush or chew.\nTake at the same time each day to maintain stable drug levels.\nKey Benefits of Pyritigmin Riva 3\nImproves Memory Retention – Enhances recall ability and reduces forgetfulness.\nSlows Symptom Progression – Delays worsening of dementia symptoms.\nSupports Daily Activities – Helps patients maintain independence in dressing, eating, and communication.\nDual Action in Dementia – Effective in both Alzheimer’s disease and Parkinson’s-related dementia.\nWell-Tolerated Formulation – Designed for safe, effective long-term use.\nPossible Side Effects\nLike all medications, Pyritigmin Riva 3 may cause side effects in some individuals.\nCommon Side Effects:\nNausea\nVomiting\nLoss of appetite\nDizziness\nStomach pain\nDiarrhea\nSerious Side Effects (rare):\nSevere weight loss\nFainting or irregular heartbeat\nSeizures\nSevere allergic reaction (rash, swelling, breathing difficulty)\nPrecautions and Warnings\nInform your doctor if you have a history of heart problems, asthma, peptic ulcers, or seizures.\nUse with caution in patients with low body weight.\nAvoid alcohol, as it may worsen side effects.\nNot recommended during pregnancy or breastfeeding unless prescribed by a doctor.\nShould be used only under strict medical supervision.\nDrug Interactions\nRivastigmine may interact with:\nOther cholinergic drugs (donepezil, galantamine) – risk of side effects increases.\nAnticholinergic drugs – reduced effectiveness.\nBeta-blockers – may increase risk of slow heart rate.\nNSAIDs (like ibuprofen, aspirin) – may increase stomach irritation risk.\nAlways inform your healthcare provider about all medications you are taking.\nWhy Choose Steris Healthcare for Pyritigmin Riva 3?\nSteris Healthcare is a leading pharmaceutical company recognized for its commitment to quality, safety, and affordability. By choosing Pyritigmin Riva 3, patients and caregivers can trust:\nWHO-GMP Certified Manufacturing – Assuring international quality standards.\nStringent Quality Control – Every batch is tested for safety and efficacy.\nAffordable Pricing – Making dementia care accessible for all patients.\nPan-India Distribution – Easy availability across pharmacies and hospitals.\nPatient-Centric Approach – Focused on improving patient outcomes and quality of life.\nSteris Healthcare ensures that Pyritigmin Riva 3 (Rivastigmine Capsules IP 3 mg) is a reliable, safe, and effective solution for managing dementia-related symptoms.", "price": 250.0, "discountamount": 175.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2177, "imageuri": "https://productimages.withfloats.com/actual/68beb3505b1b9933009f8517.png", "tileimageuri": "https://productimages.withfloats.com/tile/68beb3505b1b9933009f8517.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-08T10:43:21.61Z", "updatedon": "2025-09-08T10:43:21.61Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/rivastigmine-capsules-ip-3-mg/2177", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PYRITIGMIN RIVA 3", "category": "NEUROLOGY RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68134d097702eb2332e5ccb0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLICLAGLAZE 40", "description": "GLICLAGLAZE 40 is an oral antidiabetic medication containing Gliclazide 40 mg, formulated to effectively manage Type 2 Diabetes Mellitus. It belongs to the class of drugs known as sulfonylureas, which are specifically designed to control blood glucose levels in adults who cannot manage diabetes through diet and exercise alone. By promoting insulin secretion and improving glycemic control, GLICLAGLAZE 40 helps prevent long-term complications associated with uncontrolled diabetes, such as nerve damage, kidney issues, and cardiovascular diseases.\n\nKey Ingredient\nGliclazide (40 mg):\nGliclazide is a second-generation sulfonylurea, known for its dual effect: stimulating insulin release from the pancreas and offering antioxidant properties. It not only lowers blood sugar but also provides vascular protection, making it suitable for patients at risk of cardiovascular events.\n\nKey Benefits\nEffectively reduces high blood sugar levels in Type 2 diabetes\n\nStimulates natural insulin secretion from pancreatic beta cells\n\nProvides cardiovascular protection by improving endothelial function\n\nMinimizes the risk of microvascular complications like retinopathy and nephropathy\n\nSuitable for long-term glycemic control when lifestyle measures are insufficient\n\nHelps maintain a stable glucose profile throughout the day\n\nHow Does It Work?\nGLICLAGLAZE 40 works by targeting the pancreas to enhance the secretion of insulin, which is essential for lowering blood glucose levels. Gliclazide binds to specific receptors on pancreatic beta cells, triggering the release of insulin in a glucose-dependent manner. This ensures that the medication works primarily when glucose levels are elevated, thus reducing the risk of hypoglycemia compared to older sulfonylureas. Additionally, its antioxidant properties contribute to improved vascular health, protecting blood vessels from oxidative damage often seen in diabetic patients.\n\nDirections for Use\nTake GLICLAGLAZE 40 exactly as prescribed by your healthcare provider\n\nUsually taken once or twice daily, preferably before meals\n\nSwallow the tablet whole with water — do not crush or chew\n\nMaintain a regular schedule for meals and medication to avoid hypoglycemia\n\nMonitor blood glucose levels regularly to track progress\n\nAlways combine with a balanced diet and exercise plan for optimal results\n\nSide Effects\nThough generally well-tolerated, GLICLAGLAZE 40 may cause some side effects:\n\nCommon Side Effects:\n\nHypoglycemia (low blood sugar)\n\nHeadache\n\nDizziness or light-headedness\n\nNausea or stomach discomfort\n\nWeight gain (in some patients)\n\nRare but Serious Side Effects:\n\nLiver enzyme abnormalities\n\nSkin rash or allergic reaction\n\nBlood disorders like anemia or thrombocytopenia\n\nVisual disturbances (usually temporary)\n\nSeek immediate medical attention if symptoms of severe hypoglycemia, such as confusion, fainting, or seizures, occur.", "price": 120.0, "discountamount": 34.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "gliclaglaze 40", "exercise plan", "balanced diet", "meals swallow", "nephropathy suitable", "gliclaglaze 40gliclaglaze 40", "seizures occur", "confusion fainting", "severe hypoglycemia", "medical attention", "temporary seek", "patients rare", "lightheadedness nausea", "track progress", "regular schedule", "daily preferably", "healthcare provider", "oxidative damage", "hypoglycemia compared", "glucosedependent manner", "specific receptors", "lifestyle measures", "microvascular complications", "secondgeneration sulfonylurea", "uncontrolled diabetes", "manage diabetes", "specifically designed", "chew maintain", "glucose levels", "cardiovascular protection", "promoting insulin secretion", "diabetic patients directions", "older sulfonylureas additionally", "medication works primarily", "oral antidiabetic medication", "stable glucose profile", "insufficient helps maintain", "vascular protection making", "thrombocytopenia visual disturbances", "antioxidant properties contribute", "longterm glycemic control", "pancreatic beta cells", "lowers blood sugar", "offering antioxidant properties" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2099, "imageuri": "https://productimages.withfloats.com/actual/68134d0b4b698d44a8c316f4.png", "tileimageuri": "https://productimages.withfloats.com/tile/68134d0b4b698d44a8c316f4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-01T10:29:29.141Z", "updatedon": "2025-05-01T10:29:29.141Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/gliclaglaze-40/2099", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Gliclazide 40 mg", "category": "DIABETIC RANGE", "tags": [ "Gliclazide 40 mg uses in Hindi", "Gliclazide 40mg brands", "Gliclazide 40 mg price", "Gliclazide 40mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67d80056214eed41cf58a0ab", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Pancreatin Minimicrospheres 400mg", "description": "Pancreate 40000 is a high-quality medication designed to aid individuals with pancreatic insufficiency or conditions that affect the digestion and absorption of nutrients. Formulated with a potent blend of pancrelipase, this product supports the proper breakdown and absorption of fats, proteins, and carbohydrates in the digestive system. Pancreate 40000 is specifically tailored to provide relief for individuals suffering from pancreatic insufficiency, cystic fibrosis, and other related digestive disorders, ensuring optimal digestive function and improved nutrient absorption.\n\n \n\nKey Benefits:\n \n\nEnhanced Digestion: Pancreate 40000 contains pancrelipase, which helps break down fats, proteins, and carbohydrates, improving digestion and nutrient absorption.\nRelieves Digestive Symptoms: It helps alleviate symptoms of malabsorption, such as bloating, diarrhea, and fatty stools, by enhancing digestive enzyme activity.\nSupports Pancreatic Function: This formulation is designed to compensate for insufficient pancreatic enzyme production, aiding in the effective breakdown of food.\nImproves Nutrient Absorption: Regular use of Pancreate 40000 can promote better absorption of vital nutrients, contributing to overall health and well-being.\n \n\nHow Does It Work?\n \n\nPancreate 40000 works by providing a high concentration of pancreatic enzymes—specifically amylase, lipase, and protease. These enzymes are essential for breaking down carbohydrates, fats, and proteins in the digestive system. In individuals with pancreatic insufficiency, the body is unable to produce enough of these enzymes, leading to impaired digestion and nutrient malabsorption. By supplementing these enzymes, Pancreate 40000 helps restore normal digestion, reduce discomfort, and improve nutrient uptake.\n\n \n\nDirections for Use:\n \n\nDosage: Take the prescribed number of capsules of Pancreate 40000 with each meal or snack, as directed by your healthcare provider.\nAdministration: Swallow the capsule whole with water. Do not crush, chew, or break the capsule, as this may interfere with the enzyme release.\nConsistency: For optimal results, take Pancreate 40000 consistently with every meal or snack to ensure continuous digestive support.\n \n\nSide Effects:\n \n\nWhile Pancreate 40000 is generally safe when used as directed, some individuals may experience mild side effects, including:\n\nCommon Side Effects: Abdominal discomfort, bloating, nausea, or diarrhea.\nSerious Side Effects: In rare cases, serious allergic reactions, including skin rash, swelling, or difficulty breathing, may occur. Seek immediate medical attention if any severe allergic reactions, signs of infection, or unusual digestive symptoms develop.", "price": 1350.0, "discountamount": 405.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "pancreate 40000", "pancreate 40000 consistently", "nutrient malabsorption", "enzymes leading", "bloating diarrhea", "individuals suffering", "aid individuals", "fats proteins", "medical attention", "occur seek", "difficulty breathing", "allergic reactions", "rare cases", "side effects", "generally safe", "optimal results", "crush chew", "prescribed number", "impaired digestion", "digestive system", "carbohydrates fats", "high concentration", "effective breakdown", "fatty stools", "helps break", "provide relief", "specifically tailored", "proper breakdown", "product supports", "potent blend", "pancreatic insufficiency", "nutrients formulated", "carbohydrates improving digestion", "highquality medication designed", "vital nutrients contributing", "helps alleviate symptoms", "skin rash swelling", "enzyme release consistency" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2067, "imageuri": "https://productimages.withfloats.com/actual/67d80070ff49cc3704c7da39.png", "tileimageuri": "https://productimages.withfloats.com/tile/67d80070ff49cc3704c7da39.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-03-17T10:58:30.007Z", "updatedon": "2025-03-17T10:58:55.811Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/pancreatin-minimicrospheres-400mg/2067", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Pancreate 40000", "category": "GASTROLOGYRANGE", "tags": [ "Pancreatin tablets uses", "Pancreatin tablet side effects", "Pancreatin Tablet price", "Pancreatin 40000", "Pancreatin tablet dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e8611b9f7300708fe1240", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRIOGLIMITERIS 1/0.2 ", "description": "TRIOGLIMITERIS 1/0.2 \nVoglibose 0.2 mg, Glimepiride 1 mg & Metformin Hydrochloride 500 mg\nIntroduction\n\nTRIOGLIMITERIS 1/0.2 is a combination medication containing Voglibose, Glimepiride, and Metformin Hydrochloride. It is primarily used in the management of type 2 diabetes mellitus to improve glycemic control through different mechanisms of action targeting glucose metabolism.\n\nComposition\n\nVoglibose (0.2 mg): An alpha-glucosidase inhibitor that delays the digestion of carbohydrates in the intestine, thereby reducing postprandial blood glucose levels.\nGlimepiride (1 mg): A sulfonylurea derivative that stimulates insulin release from pancreatic beta cells, enhancing glucose uptake in peripheral tissues.\nMetformin Hydrochloride (500 mg): A biguanide that decreases hepatic glucose production, improves insulin sensitivity in peripheral tissues, and reduces intestinal glucose absorption.\nMechanism of Action\n\nTRIOGLIMITERIS 1/0.2 combines the actions of its components to achieve optimal glycemic control:\n\nVoglibose: Inhibits alpha-glucosidase enzymes in the intestine, delaying carbohydrate digestion and reducing the absorption of glucose after meals.\nGlimepiride: Stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner, thereby lowering blood glucose levels.\nMetformin Hydrochloride: Decreases hepatic glucose production through suppression of gluconeogenesis and enhances peripheral glucose uptake and utilization by improving insulin sensitivity.\nIndications\n\nTRIOGLIMITERIS 1/0.2 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults when diet, exercise, and monotherapy with metformin or sulfonylureas alone are not sufficient.\nDosage and Administration\n\nThe typical dosage of TRIOGLIMITERIS 1/0.2 is one tablet taken orally with meals, usually once or twice daily.\nDosage adjustments may be required based on individual patient response, blood glucose levels, and renal function.\nIt is essential to adhere to the prescribed dosage regimen to achieve optimal therapeutic outcomes.\nSide Effects\n\nCommon side effects of TRIOGLIMITERIS 1/0.2 may include:\n\nHypoglycemia (especially when used in combination with insulin or other antidiabetic medications)\nGastrointestinal disturbances (such as nausea, vomiting, diarrhea, or abdominal discomfort)\nWeight gain (mainly associated with sulfonylureas)\nMore severe side effects can include:\n\nAllergic reactions (rash, itching, swelling)\nLactic acidosis (rare but serious adverse effect associated with metformin use)\nHepatic dysfunction (monitor liver function tests periodically)\nPrecautions\n\nUse with caution in patients with renal impairment, hepatic dysfunction, or other significant medical conditions that may affect drug metabolism or excretion.\nRegular monitoring of blood glucose levels, renal function, and liver function is recommended during treatment with TRIOGLIMITERIS 1/0.2.\nAvoid use in patients with type 1 diabetes mellitus or diabetic ketoacidosis.\nDrug Interactions\n\nTRIOGLIMITERIS 1/0.2 may interact with other medications affecting blood glucose levels, such as insulin, other oral antidiabetic agents, or drugs that affect renal function or hepatic metabolism. Close monitoring and dose adjustments may be necessary.\nConclusion\n\nTRIOGLIMITERIS 1/0.2 provides a comprehensive approach to managing type 2 diabetes mellitus by combining Voglibose, Glimepiride, and Metformin Hydrochloride. This combination targets different aspects of glucose metabolism, enhancing insulin secretion, reducing hepatic glucose production, and delaying carbohydrate absorption in the intestine. Proper dosage, administration, and monitoring for side effects are essential to achieve and maintain optimal glycemic control in diabetic patients using TRIOGLIMITERIS 1/0.2. Consultation with a healthcare provider is recommended for personalized treatment plans and management of diabetes with this medication.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 195.0, "discountamount": 58.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "500 mg", "0.2 mg", "one tablet", "Weight gain", "Glimepiride 1", "metformin use", "Proper dosage", "Glimepiride (1", "dosage regimen", "typical dosage", "renal function", "insulin release", "drug metabolism", "Lactic acidosis", "Close monitoring", "dose adjustments", "renal impairment", "diabetic patients", "insulin secretion", "different aspects", "Drug Interactions", "other medications", "Regular monitoring", "Dosage adjustments", "Allergic reactions", "peripheral tissues", "hepatic metabolism", "glucose metabolism", "insulin sensitivity", "healthcare provider", "Hepatic dysfunction", "Common side effects", "abdominal discomfort", "different mechanisms", "liver function tests", "diabetic ketoacidosis", "pancreatic beta cells", "combination medication", "carbohydrate digestion", "comprehensive approach", "serious adverse effect", "Metformin Hydrochloride", "carbohydrate absorption", "sulfonylurea derivative", "glucose-dependent manner", "optimal glycemic control", "type 1 diabetes mellitus", "type 2 diabetes mellitus", "More severe side effects", "alpha-glucosidase enzymes", "peripheral glucose uptake", "hepatic glucose production", "alpha-glucosidase inhibitor", "individual patient response", "personalized treatment plans", "optimal therapeutic outcomes", "Gastrointestinal disturbances", "intestinal glucose absorption", "other antidiabetic medications", "other oral antidiabetic agents", "postprandial blood glucose levels", "other significant medical conditions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1939, "imageuri": "https://productimages.withfloats.com/actual/668e86143a68154e11e7d822.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e86143a68154e11e7d822.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T13:01:05.875Z", "updatedon": "2024-07-10T13:01:05.875Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trioglimiteris-1-0-2-/1939", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRIOGLIMITERIS 1/0.2 ", "category": "DIABETIC RANGE", "tags": [ "glimepiride 1mg+metformin 500mg+voglibose 0.2 mg", "Glimepiride 2mg Metformin 500mg Voglibose 0.2 mg b", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg", "voglibose glimepiride & metformin hydrochloride (s", "voglibose glimepiride + metformin hydrochloride us", "glimepiride 1mg+metformin 500mg+voglibose 0.3 mg", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg g", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e6fa253fc1c22985081c8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SLIM BOOST CTSTAT 120 ", "description": "SLIM BOOST CTSTAT 120 \nCetilistat (120mg)\nIntroduction\nSLIM BOOST CTSTAT 120 is an advanced weight management medication containing Cetilistat (120mg), a potent oral lipase inhibitor aimed at aiding weight reduction in individuals struggling with obesity. By preventing the digestion and absorption of dietary fats, Cetilistat helps decrease caloric intake, facilitating weight loss when combined with a reduced-calorie diet and appropriate physical activity.\n\nComposition\n\nCetilistat (120mg): A lipase inhibitor that specifically targets and inhibits gastrointestinal lipases, crucial enzymes for the digestion of fats.\nMechanism of Action\nCetilistat works by inhibiting the action of pancreatic lipase, an enzyme necessary for the breakdown of triglycerides in the intestine. When lipase activity is blocked, triglycerides from the diet are not hydrolyzed into absorbable free fatty acids and monoglycerides. Instead, undigested triglycerides are excreted in the feces, leading to reduced calorie absorption and aiding weight loss.\n\nIndications\nSLIM BOOST CTSTAT 120 is indicated for:\n\nObesity Management: To assist in weight reduction for obese patients with a body mass index (BMI) of 30 or higher.\nWeight Loss for Overweight Patients: With a BMI of 27 or higher who also have risk factors such as diabetes, hypertension, or dyslipidemia.\nDosage and Administration\n\nRecommended Dosage: The typical dosage is 120mg taken three times daily with or up to one hour after meals containing fat.\nAdministration: It should be taken with water and alongside a nutritionally balanced, reduced-calorie diet that contains approximately 30% of calories from fat. Following dietary recommendations is crucial to minimize gastrointestinal side effects and enhance weight loss efficacy.\nSide Effects\nCommon side effects may include:\n\nGastrointestinal issues such as oily spotting, flatulence with discharge, fecal urgency, fatty/oily stool, increased defecation, and fecal incontinence.\nAbdominal pain or discomfort\nDiarrhea\nNausea\nThese side effects are typically related to the drug's mechanism of action and can often be managed by adhering to the recommended dietary guidelines.\n\nPrecautions\n\nChronic Malabsorption Syndrome: Cetilistat should not be used in patients with chronic malabsorption syndrome.\nCholestasis: It is contraindicated in patients with cholestasis (a condition where bile flow from the liver is blocked).\nFat-Soluble Vitamins: Cetilistat may impair the absorption of fat-soluble vitamins (A, D, E, and K). It is recommended to take a multivitamin supplement at least 2 hours before or after taking Cetilistat.\nDrug Interactions\n\nCyclosporine: Concomitant use may decrease cyclosporine levels; it should be administered 2 hours before or after Cetilistat.\nWarfarin: Close monitoring of anticoagulant effects is necessary when co-administered, as Cetilistat may affect vitamin K absorption.\nFat-Soluble Vitamins and Supplements: Ensure adequate intake of vitamins A, D, E, and K by taking a multivitamin supplement.\nConclusion\nSLIM BOOST CTSTAT 120, with its active ingredient Cetilistat, provides an effective solution for managing obesity and supporting weight loss efforts. By inhibiting fat absorption, it helps reduce caloric intake, contributing to weight loss when combined with a balanced, reduced-calorie diet and regular physical activity. It is essential to use this medication under the guidance of a healthcare professional to ensure safe and effective weight loss while minimizing potential side effects and nutrient deficiencies. Adhering to dietary recommendations and monitoring for any adverse effects will help achieve the best outcomes with SLIM BOOST CTSTAT 120.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n\n", "price": 580.0, "discountamount": 174.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "bile flow", "vitamins A", "dietary fats", "risk factors", "best outcomes", "fecal urgency", "oily spotting", "fat absorption", "obese patients", "typical dosage", "Abdominal pain", "caloric intake", "adequate intake", "Concomitant use", "crucial enzymes", "adverse effects", "lipase activity", "body mass index", "Close monitoring", "fatty/oily stool", "weight reduction", "Drug Interactions", "active ingredient", "pancreatic lipase", "SLIM BOOST CTSTAT", "Recommended Dosage", "dietary guidelines", "fecal incontinence", "Obesity Management", "effective solution", "cyclosporine levels", "Overweight Patients", "weight loss efforts", "Common side effects", "Fat-Soluble Vitamins", "weight loss efficacy", "vitamin K absorption", "nutrient deficiencies", "anticoagulant effects", "effective weight loss", "potential side effects", "healthcare professional", "multivitamin supplement", "dietary recommendations", "Gastrointestinal issues", "undigested triglycerides", "gastrointestinal lipases", "regular physical activity", "reduced calorie absorption", "absorbable free fatty acids", "potent oral lipase inhibitor", "gastrointestinal side effects", "appropriate physical activity", "balanced, reduced-calorie diet", "Chronic Malabsorption Syndrome", "advanced weight management medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1932, "imageuri": "https://productimages.withfloats.com/actual/68316fd9ab217a50d26b6b09.png", "tileimageuri": "https://productimages.withfloats.com/tile/68316fd9ab217a50d26b6b09.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T11:25:22.65Z", "updatedon": "2025-05-24T07:05:59.696Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/slim-boost-ctstat-120-/1932", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Cetilistat (120mg)", "category": "GENERAL RANGE", "tags": [ "Cetilistat vs orlistat", "Cetilistat dosage", "Cetilistat side effects", "Cetilistat 120 mg side effects", "Cetilistat 120 mg brands in india", "Cetilistat 120 mg Uses in Hindi", "Cetilistat Tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e6cdd5c559a0c24bb221a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SLIM BOOST CTSTAT 60 ", "description": "SLIM BOOST CTSTAT 60 \nCetilistat (60mg)\nIntroduction\nSLIM BOOST CTSTAT 60 is a weight management medication containing Cetilistat (60mg), an oral lipase inhibitor designed to assist in weight reduction in individuals with obesity. By inhibiting the digestion and absorption of dietary fats, Cetilistat helps reduce caloric intake, promoting weight loss when used in conjunction with a reduced-calorie diet and appropriate physical activity.\n\nComposition\n\nCetilistat (60mg): A novel lipase inhibitor that targets gastrointestinal lipases, crucial enzymes for fat digestion.\nMechanism of Action\nCetilistat works by inhibiting pancreatic lipase, an enzyme necessary for the breakdown of triglycerides in the intestine. When lipase activity is blocked, triglycerides from the diet are not hydrolyzed into absorbable free fatty acids and monoglycerides. Instead, undigested triglycerides are excreted, reducing the overall caloric intake and aiding weight loss.\n\nIndications\nSLIM BOOST CTSTAT 60 is indicated for:\n\nObesity Management: To assist in weight reduction for obese patients with a body mass index (BMI) of 30 or higher.\nWeight Loss for Overweight Patients: With a BMI of 27 or higher who also have risk factors such as diabetes, hypertension, or dyslipidemia.\nDosage and Administration\n\nRecommended Dosage: The typical dosage is 60mg taken three times daily with or up to one hour after meals containing fat.\nAdministration: It should be taken with water and in conjunction with a nutritionally balanced, reduced-calorie diet that contains approximately 30% of calories from fat. Adherence to dietary recommendations is crucial to minimize gastrointestinal side effects and enhance weight loss efficacy.\nSide Effects\nCommon side effects may include:\n\nGastrointestinal issues such as oily spotting, flatulence with discharge, fecal urgency, fatty/oily stool, increased defecation, and fecal incontinence.\nAbdominal pain or discomfort\nDiarrhea\nNausea\nThese side effects are typically related to the drug's mechanism of action and can often be managed by adhering to the recommended dietary guidelines.\n\nPrecautions\n\nChronic Malabsorption Syndrome: Cetilistat should not be used in patients with chronic malabsorption syndrome.\nCholestasis: It is contraindicated in patients with cholestasis (a condition where bile flow from the liver is blocked).\nFat-Soluble Vitamins: Cetilistat may impair the absorption of fat-soluble vitamins (A, D, E, and K). It is recommended to take a multivitamin supplement at least 2 hours before or after taking Cetilistat.\nDrug Interactions\n\nCyclosporine: Concomitant use may decrease cyclosporine levels; it should be administered 2 hours before or after Cetilistat.\nWarfarin: Close monitoring of anticoagulant effects is necessary when co-administered, as Cetilistat may affect vitamin K absorption.\nFat-Soluble Vitamins and Supplements: Ensure adequate intake of vitamins A, D, E, and K by taking a multivitamin supplement.\nConclusion\nSLIM BOOST CTSTAT 60, with its active ingredient Cetilistat, offers an effective solution for weight management in obese and overweight individuals. By inhibiting fat absorption, it helps reduce caloric intake, contributing to weight loss when combined with a balanced, reduced-calorie diet and regular physical activity. It is essential to use this medication under the guidance of a healthcare professional to ensure safe and effective weight loss while minimizing potential side effects and nutrient deficiencies. Always adhere to dietary recommendations and monitor for any adverse effects to achieve the best outcomes with SLIM BOOST CTSTAT 60.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 450.0, "discountamount": 135.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "bile flow", "vitamins A", "risk factors", "dietary fats", "fat digestion", "best outcomes", "fecal urgency", "oily spotting", "obese patients", "fat absorption", "typical dosage", "Abdominal pain", "Concomitant use", "crucial enzymes", "adequate intake", "adverse effects", "lipase activity", "body mass index", "Close monitoring", "fatty/oily stool", "weight reduction", "Drug Interactions", "active ingredient", "pancreatic lipase", "SLIM BOOST CTSTAT", "Recommended Dosage", "Obesity Management", "dietary guidelines", "fecal incontinence", "effective solution", "cyclosporine levels", "Overweight Patients", "Common side effects", "Fat-Soluble Vitamins", "weight loss efficacy", "vitamin K absorption", "nutrient deficiencies", "anticoagulant effects", "effective weight loss", "oral lipase inhibitor", "overweight individuals", "overall caloric intake", "potential side effects", "novel lipase inhibitor", "healthcare professional", "multivitamin supplement", "dietary recommendations", "Gastrointestinal issues", "undigested triglycerides", "gastrointestinal lipases", "regular physical activity", "absorbable free fatty acids", "weight management medication", "gastrointestinal side effects", "appropriate physical activity", "balanced, reduced-calorie diet", "Chronic Malabsorption Syndrome" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1931, "imageuri": "https://productimages.withfloats.com/actual/668e6cdfa916e42e88302495.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e6cdfa916e42e88302495.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T11:13:33.226Z", "updatedon": "2024-07-10T11:13:33.226Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/slim-boost-ctstat-60-/1931", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SLIM BOOST CTSTAT 60 ", "category": "GENERAL RANGE", "tags": [ "Cetilistat vs orlistat", "Cetilistat 120 mg Uses in Hindi", "", "Cetilistat dosage", "Cetilistat Tablets", "Cetilistat Brand name", "Cetilistat side effects", "Cetilistat 120 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662c81c7247ae19c482b3d9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VILDIABATE 100 ", "description": "VILDIABATE 100 \nVildagliptin (100mg)\nIntroduction to VILDIABATE 100\nVILDIABATE 100 is an oral medication designed for the management of type 2 diabetes mellitus. It contains Vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor. Vildagliptin helps regulate blood sugar levels by enhancing the body’s natural ability to produce insulin and control glucose production. This medication is used in conjunction with diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nKey Component and Mechanism of Action\nVildagliptin 100mg\nVildagliptin is a potent and selective DPP-4 inhibitor. It works by inhibiting the DPP-4 enzyme, which is responsible for breaking down incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These incretin hormones play a crucial role in glucose metabolism:\n\nGLP-1: Stimulates insulin secretion from the pancreatic beta cells in a glucose-dependent manner, inhibits glucagon release, slows gastric emptying, and reduces appetite.\nGIP: Enhances insulin secretion post-meal, aiding in the regulation of blood glucose levels.\nBy increasing the levels of these incretin hormones, Vildagliptin helps to improve insulin secretion in response to meals and reduces the amount of glucose produced by the liver.\n\nBenefits of VILDIABATE 100\nEffective Blood Sugar Control\nPostprandial Glucose Control: VILDIABATE 100 helps manage postprandial (after-meal) blood sugar levels by enhancing the body's natural response to food intake.\nFasting Glucose Control: By reducing hepatic glucose production, it also helps lower fasting blood sugar levels.\nAdditional Health Benefits\nLow Risk of Hypoglycemia: Vildagliptin has a low risk of causing hypoglycemia (low blood sugar) because it enhances insulin secretion only when blood glucose levels are elevated.\nWeight Neutral: Vildagliptin is generally weight neutral, making it a favorable option for patients concerned about weight gain associated with other diabetes medications.\nHow to Use VILDIABATE 100\nDosage and Administration\nRecommended Dosage: The typical dosage of VILDIABATE 100 is one tablet taken once or twice daily, depending on individual needs and the healthcare provider's instructions.\nAdministration: Take the tablet with or without food. Swallow it whole with a glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take VILDIABATE 100 regularly at the same time each day as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regular monitoring of blood sugar levels is important to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vildiabate-100-133452", "price": 275.0, "discountamount": 82.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "diet", "body", "EMAIL", "Order", "meals", "water", "glass", "GLP-1", "liver", "adults", "Action", "amount", "option", "potent", "readings", "Low Risk", "appetite", "exercise", "patients", "same time", "Mechanism", "regulation", "VILDIABATE", "one tablet", "Guidelines", "management", "food intake", "weight gain", "Optimal Use", "information", "conjunction", "Adjustments", "Introduction", "Vildagliptin", "sterisonline", "best results", "crucial role", "DPP-4 enzyme", "Hypoglycemia", "instructions", "sterispharma", "Key Component", "CALL/WHATSAPP", "typical dosage", "Consistent Use", "Administration", "treatment plan", "Weight Neutral", "natural ability", "oral medication", "low blood sugar", "glucagon release", "DPP-4) inhibitor", "natural response", "glycemic control", "individual needs", "gastric emptying", "insulin secretion", "incretin hormones", "glucose metabolism", "Recommended Dosage", "Regular monitoring", "healthcare provider", "blood glucose levels", "pancreatic beta cells", "dipeptidyl peptidase-4", "Fasting Glucose Control", "meal) blood sugar levels", "type 2 diabetes mellitus", "glucose-dependent manner", "selective DPP-4 inhibitor", "Additional Health Benefits", "hepatic glucose production", "other diabetes medications", "Postprandial Glucose Control", "Effective Blood Sugar Control", "glucose-dependent insulinotropic peptide" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1514, "imageuri": "https://productimages.withfloats.com/actual/667d3bc9c134db5b38ba8354.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d3bc9c134db5b38ba8354.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T08:43:08.09Z", "updatedon": "2024-06-27T10:15:31.785Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/vildiabate-100-/1514", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VILDIABATE 100 ", "category": "DIABETIC RANGE", "tags": [ "vildagliptin 100 mg uses", "", "vildagliptin 100 mg generic medicine", "vildagliptin 100 mg side effects", "", "vildagliptin sustained release tablets 100 mg", "vildagliptin 100 mg brands in india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662acf3161afa2274ff5e9d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VILDIABATE 50 ", "description": "VILDIABATE 50 \nVildagliptin (50mg)\nIntroduction to VILDIABATE 50\nVILDIABATE 50 is an oral medication specifically designed for the management of type 2 diabetes mellitus. It contains Vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor. Vildagliptin works by enhancing the body's natural ability to regulate blood sugar levels, especially after meals. This medication is used in conjunction with diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nMechanism of Action\nVildagliptin\nVildagliptin is a potent and selective DPP-4 inhibitor. It works by inhibiting the DPP-4 enzyme, which degrades incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These hormones play a crucial role in glucose metabolism:\n\nGLP-1: Stimulates insulin secretion from the pancreatic beta cells in a glucose-dependent manner, inhibits glucagon release, slows gastric emptying, and reduces appetite.\nGIP: Enhances insulin secretion post-meal, aiding in the regulation of blood glucose levels.\nBy increasing the levels of these incretin hormones, Vildagliptin helps to improve insulin release in response to meals and reduces the amount of glucose produced by the liver.\n\nBenefits of VILDIABATE 50\nEffective Blood Sugar Control\nPostprandial Glucose Control: VILDIABATE 50 helps manage postprandial (after-meal) blood sugar levels by enhancing the body's natural response to food intake.\nFasting Glucose Control: By reducing hepatic glucose production, it also helps lower fasting blood sugar levels.\nAdditional Health Benefits\nLow Risk of Hypoglycemia: Vildagliptin has a low risk of causing hypoglycemia (low blood sugar) because it enhances insulin secretion only when blood glucose levels are elevated.\nWeight Neutral: Vildagliptin is generally weight neutral, making it a favorable option for patients concerned about weight gain associated with other diabetes medications.\nHow to Use VILDIABATE 50\nDosage and Administration\nRecommended Dosage: The typical dosage of VILDIABATE 50 is one tablet taken once or twice daily, depending on individual needs and the healthcare provider's instructions.\nAdministration: Take the tablet with or without food. Swallow it whole with a glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take VILDIABATE 50 regularly at the same time each day as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regular monitoring of blood sugar levels is important to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vildiabate-50-133451", "price": 249.0, "discountamount": 74.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "body", "diet", "liver", "Order", "glass", "meals", "water", "EMAIL", "GLP-1", "option", "potent", "adults", "amount", "readings", "Low Risk", "appetite", "patients", "exercise", "Mechanism", "same time", "one tablet", "regulation", "VILDIABATE", "Guidelines", "management", "Adjustments", "weight gain", "information", "Optimal Use", "food intake", "conjunction", "Introduction", "sterisonline", "crucial role", "DPP-4 enzyme", "Hypoglycemia", "instructions", "sterispharma", "best results", "CALL/WHATSAPP", "treatment plan", "Consistent Use", "Weight Neutral", "typical dosage", "Administration", "natural ability", "oral medication", "low blood sugar", "insulin release", "glucagon release", "natural response", "DPP-4) inhibitor", "gastric emptying", "individual needs", "glycemic control", "incretin hormones", "insulin secretion", "Regular monitoring", "glucose metabolism", "Recommended Dosage", "Action Vildagliptin", "healthcare provider", "blood glucose levels", "pancreatic beta cells", "dipeptidyl peptidase-4", "Fasting Glucose Control", "meal) blood sugar levels", "type 2 diabetes mellitus", "glucose-dependent manner", "selective DPP-4 inhibitor", "other diabetes medications", "hepatic glucose production", "Additional Health Benefits", "Postprandial Glucose Control", "Effective Blood Sugar Control", "glucose-dependent insulinotropic peptide" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1494, "imageuri": "https://productimages.withfloats.com/actual/6662acf5364f23242470bc7d.png", "tileimageuri": "https://productimages.withfloats.com/tile/6662acf5364f23242470bc7d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T06:47:15.345Z", "updatedon": "2024-06-28T11:41:29.762Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/vildiabate-50-/1494", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VILDIABATE 50 ", "category": "DIABETIC RANGE", "tags": [ "VILDIABATE 50", "Vildagliptin (50mg)", "Vildagliptin 50mg side effects", "Vildagliptin tablets 50 mg uses", "Vildagliptin 50 mg price", "Vildagliptin 50 mg and metformin 500 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662aa04db100e1fdc2dcb68", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VILDIABATE 100 ", "description": "VILDIABATE 100 \nVildagliptin (100mg)\nVILDIABATE 100 is a medication designed to manage type 2 diabetes mellitus by targeting specific aspects of glucose regulation. It contains Vildagliptin, an oral antidiabetic agent that belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. Vildagliptin works by inhibiting the enzyme DPP-4, which is responsible for degrading incretin hormones like GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide).\n\nHere are key points about VILDIABATE 100:\n\nMechanism of Action: Vildagliptin acts by inhibiting DPP-4, thereby increasing the levels of GLP-1 and GIP. These hormones play crucial roles in glucose metabolism:\n\nGLP-1 stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner. It also inhibits glucagon secretion, reduces appetite, and slows gastric emptying.\nGIP enhances insulin release in response to meals, contributing to postprandial glucose control.\nBlood Sugar Control: By enhancing insulin secretion and reducing glucagon levels, VILDIABATE 100 helps lower blood sugar levels, especially after meals. This mechanism targets both fasting and postprandial hyperglycemia, contributing to overall glycemic control.\n\nDosage and Administration: VILDIABATE 100 is typically taken orally once daily, preferably with a meal to maximize its effects on postprandial glucose levels. The dosage may vary depending on individual needs and response to treatment. It's essential to follow your healthcare provider's instructions regarding dosage and timing.\n\nEfficacy and Safety: Clinical studies have demonstrated the efficacy of Vildagliptin in lowering HbA1c levels (a marker of long-term glucose control) and improving glycemic parameters. It is generally well-tolerated, with common side effects including headache, nasopharyngitis (inflammation of the nose and throat), and upper respiratory tract infections. Serious side effects are rare but may include pancreatitis or hypersensitivity reactions.\n\nCombination Therapy: VILDIABATE 100 may be prescribed as monotherapy or in combination with other antidiabetic medications such as metformin or sulfonylureas. Combining medications with different mechanisms of action can provide synergistic benefits in managing diabetes.\n\nMonitoring and Follow-Up: Regular monitoring of blood sugar levels, kidney function, and other relevant parameters is important during treatment with VILDIABATE 100. Your healthcare provider may adjust the dosage or add/modify other medications based on your response and individual needs.\n\nLifestyle Modifications: In addition to medication, lifestyle modifications such as a healthy diet, regular exercise, weight management, and avoiding tobacco and excessive alcohol intake are essential components of diabetes management.\n\nIn conclusion, VILDIABATE 100 containing Vildagliptin is an effective oral antidiabetic medication that helps regulate blood sugar levels in patients with type 2 diabetes. It acts by enhancing insulin secretion and reducing postprandial glucose levels, contributing to improved glycemic control. However, it should be used under medical supervision, and adherence to prescribed dosage and lifestyle recommendations is crucial for optimal diabetes management.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vildiabate-100-133452\n\n\n\n\n\n", "price": 275.0, "discountamount": 82.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "nose", "GLP-1", "EMAIL", "class", "meals", "Order", "timing", "throat", "enzyme", "Safety", "Dosage", "marker", "tobacco", "fasting", "response", "addition", "appetite", "headache", "patients", "Efficacy", "metformin", "Follow-Up", "adherence", "treatment", "VILDIABATE", "conclusion", "key points", "information", "monotherapy", "healthy diet", "instructions", "sterisonline", "pancreatitis", "inflammation", "sterispharma", "HbA1c levels", "CALL/WHATSAPP", "sulfonylureas", "crucial roles", "Administration", "insulin release", "nasopharyngitis", "kidney function", "glucagon levels", "gastric emptying", "specific aspects", "Clinical studies", "individual needs", "regular exercise", "other medications", "Vildagliptin acts", "incretin hormones", "DPP-4) inhibitors", "weight management", "insulin secretion", "glucose metabolism", "glucose regulation", "glucagon secretion", "blood sugar levels", "Regular monitoring", "Combination Therapy", "glycemic parameters", "common side effects", "Blood Sugar Control", "medical supervision", "healthcare provider", "essential components", "synergistic benefits", "different mechanisms", "Serious side effects", "pancreatic beta cells", "dipeptidyl peptidase-4", "oral antidiabetic agent", "Lifestyle Modifications", "glucose-dependent manner", "excessive alcohol intake", "overall glycemic control", "type 2 diabetes mellitus", "lifestyle recommendations", "other relevant parameters", "long-term glucose control", "hypersensitivity reactions", "postprandial hyperglycemia", "optimal diabetes management", "postprandial glucose levels", "postprandial glucose control", "other antidiabetic medications", "upper respiratory tract infections", "effective oral antidiabetic medication", "glucose-dependent insulinotropic peptide" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1491, "imageuri": "https://productimages.withfloats.com/actual/6662aa0b364f23242470b3ca.png", "tileimageuri": "https://productimages.withfloats.com/tile/6662aa0b364f23242470b3ca.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T06:34:44.056Z", "updatedon": "2024-06-28T11:58:50.164Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/vildiabate-100-/1491", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VILDIABATE 100 ", "category": "DIABETIC RANGE", "tags": [ "VILDIABATE 100", "Vildagliptin (100mg)", "Vildagliptin 100 mg uses", "Vildagliptin 100 mg price", "Vildagliptin 100 mg SR brand Name", "Vildagliptin 100 mg brands in India", "", "Vildagliptin 100 mg generic medicine", "Vildagliptin 100 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }